Roche announces collaboration with Atea Pharmaceuticals to develop a potential oral treatment for COVID-19 patients

    NEXT STORY
    COVID-19 Impact on Social and Emotional Learning (SEL) Market – Global Forecast to 2026
    PREV STORY
    Ascendis Pharma A/S Announces Presentations for its Endocrinology Rare Disease Clinical Programs at Upcoming Medical Conferences
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Aptose To Release First Quarter Ended March 31, 2019 Financial Results and Hold Conference Call on May 7, 2019

    author_avatar
    NASDAQ Market News

    ABLYNX TO PRESENT AT THE 36th ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

    GHENT, Belgium, 4 January 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced ...

    author_avatar
    NASDAQ Market News

    Coherus BioSciences to Report Second Quarter 2016 Financial Results on August 9th

    REDWOOD CITY, Calif., July 25, 2016 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today ...

    author_avatar
    NASDAQ Market News